Cohen Joshua B

CIK 00018986441 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001898644

Recent Transactions

40 trades

Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2026-01-16$13.83/sh−1,974→ 3,379,465 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (Right to Buy)
2026-01-16−2,818→ 0 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2026-01-16$7.57/sh+2,818→ 3,381,439 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2026-01-15$7.57/sh+197,182→ 3,514,814 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2026-01-15$13.59/sh−136,193→ 3,378,621 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (Right to Buy)
2026-01-15−197,182→ 2,818 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2026-01-06$11.09/sh−7,715→ 3,317,632 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-09-30$15.00/sh−200→ 3,325,347 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-09-30$14.34/sh−29,733→ 3,325,547 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-03-31$3.47/sh−21,490→ 3,355,280 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-03-06+180,118→ 3,376,770 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (Right to Buy)
2025-03-06+270,177→ 270,177 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-03-03$3.17/sh−4,595→ 3,196,652 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-02-03$3.47/sh−11,851→ 3,201,247 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-01-06$4.05/sh−7,471→ 3,213,098 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-09-30$3.20/sh−18,589→ 3,220,569 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-09-23$1.57/sh+1,857→ 3,239,158 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2024-09-23−1,857→ 0 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-09-12$1.57/sh+34,449→ 3,237,301 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2024-09-12−34,449→ 1,857 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2024-04-16+380,000→ 380,000 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-04-16+179,850→ 3,202,852 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-03-05$18.73/sh−4,135→ 3,023,002 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-02-26+126,667→ 3,027,137 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2024-02-26+190,000→ 190,000 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-01-09$16.33/sh−5,841→ 2,900,470 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-11-16$1.57/sh+63,694→ 2,906,311 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (Right to Buy)
2023-11-16−63,694→ 36,306 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-03-16$31.84/sh−96,076→ 2,796,541 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-03-16+50,000→ 2,842,617 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2023-03-16+225,000→ 225,000 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-03-16$32.45/sh−3,924→ 2,792,617 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-01-06$36.79/sh+1,846→ 2,892,617 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-01-06$36.08/sh+4,122→ 2,894,463 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2022-05-05−334,520→ 0 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2022-05-05$0.37/sh+334,520→ 2,898,585 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2022-01-06+75,000→ 2,564,065 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2022-01-06+337,500→ 337,500 total
Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Series C-1 Preferred Stock
2022-01-06−4,870→ 0 total
Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2022-01-06+4,870→ 2,489,065 total

Companies

Amylyx Pharmaceuticals, Inc.
Director, Co-Chief Executive Officer
$AMLX

Recent Filings

Address

C/O AMYLYX PHARMACEUTICALS, INC. 55 CAMBRIDGE PARKWAY, SUITE 6W

CAMBRIDGE, MA, 02142

View on SEC.gov